CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
AbstractLung cancer represents the leading cause of cancer-related mortality throughout the world. Patients die of local progression, disseminated disease, or both. At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis of lung cancer is made. The high rate of brain metastasis makes lung cancer the most common type of tumor to spread to the brain. It is critical to understand the biologic basis of brain metastases to develop novel diagnostic and therapeutic approaches. This review will focus on the emerging data supporting the involvement of the chemokine CXCL12 and its receptor CXCR4 in the brain metastatic evolution of non-small-cell lung cancer (NSCLC) and the pharmacological tools that may be used to interfere with this signaling axis. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Cavallaro, S. CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain. Int. J. Mol. Sci. 2013, 14, 1713-1727.
Cavallaro S. CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain. International Journal of Molecular Sciences. 2013; 14(1):1713-1727.Chicago/Turabian Style
Cavallaro, Sebastiano. 2013. "CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain." Int. J. Mol. Sci. 14, no. 1: 1713-1727.